文献速递肝胆胰外科围术期管理与 ERAS

腹腔镜肝切除治疗肝细胞癌的复发模式、时机与预测因素:高容量肝胆胰中心结果

Patterns, timing, and predictors of recurrence after laparoscopic liver resection for hepatocellular carcinoma: results from a high-volume HPB center.
PubMed 文献 · Surg Endosc · 2021-02-23

425例LLR患者中144例(33.8%)复发,肝内复发最常见(68.8%),83.3%在术后2年内复发,未见穿刺孔复发,LLR未增加穿刺孔复发或种植风险。

要点

  • LLR后肝内复发最常见,占68.8%,穿刺孔复发未见。
  • 83.3%的复发发生在LLR术后2年内,监测应针对早期复发。
  • LLR与OLR的复发模式、时机和治疗无显著差异。

核心结论

  • 肝内复发仍是LLR治疗肝细胞癌后最常见的复发模式。
  • LLR不增加穿刺孔复发或种植风险。
  • 多数复发发生在LLR术后2年内,监测应针对早期复发。

研究设计与样本

  • 经1:2倾向性评分匹配比较LLR与OLR的复发结局。
  • 采用Cox比例风险模型评估复发潜在危险因素。

主要发现

  • 425例LLR患者中144例(33.8%)复发,中位无复发生存期(RFS)为10.0个月(范围1-58个月)。
  • 最常见复发部位为肝脏(n=99,68.8%),其次为手术切缘(n=15,10.4%)和远处转移(n=12,8.3%)。
  • 肝复发合并远处转移(n=10,6.9%)倾向于早期发生(中位8.0个月),腹膜复发(n=8,5.6%)发生较晚(中位14.0个月)。
  • 120例(83.3%)在LLR术后2年内复发,研究未观察到穿刺孔复发。
  • LLR与OLR的复发模式、时机和治疗无显著差异。

关键数值与推荐

  • 复发独立危险因素包括ALBI分级、术后α-胎蛋白 > 8 ng/ml、肿瘤大小 > 5 cm、手术切缘 ≤ 1 cm和多发肿瘤。

临床怎么用

  • LLR术后应重点监测2年内的早期复发,尤其是肝内复发。
  • 对具有ALBI分级、术后AFP > 8 ng/ml、肿瘤 > 5 cm、切缘 ≤ 1 cm或多发肿瘤等危险因素的患者加强随访。
  • LLR不增加穿刺孔复发风险,不应因此限制LLR的应用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Although long-term outcomes may be comparable between laparoscopic liver resection (LLR) and open liver resection (OLR) for hepatocellular carcinoma (HCC), there has been little discussion regarding the patterns of recurrence after LLR. METHODS: Patients with HCC who underwent hepatectomy between April 2015 and November 2018 were included in this study. The recurrence patterns were analyzed in detail. The recurrence outcomes following laparoscopic versus OLR for HCC were compared after 1:2 propensity score matching. Potential risk factors for recurrence were also assessed with Cox proportional risk models. RESULTS: Among 425 patients after LLR, 144 (33.8%) experienced recurrence at the last follow-up, with a median recurrence-free survival (RFS) of 10.0 months (range 1-58 months). The most frequent recurrence site was the liver (n = 99, 68.8%), followed by the surgical margin (n = 15, 10.4%) and distant metastases (n = 12, 8.3%). Liver recurrence with distant metastasis (n = 10, 6.9%) tended to occur early (median 8.0 months), while peritoneal recurrence (n = 8, 5.6%) occurred later (median 14.0 months). A total of 120 (83.3%) patients had recurrence within 2 years after LLR. No trocar site recurrence was observed in this study. The recurrence patterns, timing, and treatment did not show significant differences between the LLR and OLR. The independent risk factors for recurrence included ALBI grade, postoperative α-fetoprotein > 8 ng/ml, tumor size > 5 cm, surgical margin ≤ 1 cm, and multiple tumors. Patients with recurrence had 1- and 5-year overall survival rates of 81.1% and 60.7%, respectively, compared with rates of 95.8% and 92.9% for patients without recurrence (P < 0.000). CONCLUSION: This study suggested that intrahepatic recurrence was still the most common recurrence pattern for HCC after LLR and that LLR did not increase the risk of trocar hole recurrence or implantation. Most cases of recurrence occurred within 2 years after LLR, suggesting that surveillance should be targeted to early recurrence.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Zhang H, Liu F, Wen N, et al. Patterns, timing, and predictors of recurrence after laparoscopic liver resection for hepatocellular carcinoma: results from a high-volume HPB center. Surg Endosc. 2021. PMID: 33620568. doi:10.1007/s00464-021-08390-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。